Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Xenon Pharmaceuticals Profit Margin 2012-2020 | XENE

Current and historical gross margin, operating margin and net profit margin for Xenon Pharmaceuticals (XENE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Xenon Pharmaceuticals net profit margin as of March 31, 2020 is 0%.
  
Xenon Pharmaceuticals Annual Profit Margins
Xenon Pharmaceuticals Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.414B $0.007B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.932B 14.31
Gilead Sciences (GILD) United States $97.264B 12.61
CSL (CSLLY) Australia $92.662B 0.00
Vertex Pharmaceuticals (VRTX) United States $70.736B 48.63
Regeneron Pharmaceuticals (REGN) United States $65.850B 25.38
Illumina (ILMN) United States $52.685B 54.14
Biogen (BIIB) United States $48.899B 8.37
Seattle Genetics (SGEN) United States $26.040B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.104B 10.79
Moderna (MRNA) United States $22.492B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
Incyte (INCY) United States $20.390B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.442B 176.25
Genmab (GMAB) Denmark $18.912B 15.57
Genmab (GNMSF) Denmark $17.615B 52.30
Alnylam Pharmaceuticals (ALNY) United States $15.145B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
BeiGene (BGNE) Cayman Islands $13.265B 0.00
Galapagos (GLPG) Belgium $12.703B 37.62
Exact Sciences (EXAS) United States $12.698B 0.00
BioNTech SE (BNTX) Germany $11.313B 0.00
Sarepta Therapeutics (SRPT) United States $11.309B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.871B 0.00
QIAGEN (QGEN) Netherlands $10.103B 29.38
Bio-Techne Corp (TECH) United States $9.653B 63.78
Horizon Therapeutics Public (HZNP) Ireland $9.077B 22.34
Guardant Health (GH) United States $7.819B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.131B 0.00
Immunomedics (IMMU) United States $6.969B 0.00
Ascendis Pharma (ASND) Denmark $6.934B 0.00
Exelixis (EXEL) United States $6.924B 24.28
Repligen (RGEN) United States $6.372B 111.76
Adaptive Biotechnologies (ADPT) United States $4.974B 0.00
Acceleron Pharma (XLRN) United States $4.957B 0.00
MyoKardia (MYOK) United States $4.613B 0.00
Emergent Biosolutions (EBS) United States $4.447B 29.15
China Biologic Products (CBPO) China $4.316B 23.99
Reata Pharmaceuticals (RETA) United States $4.305B 0.00
MorphoSys AG (MOR) Germany $4.199B 32.57
Ultragenyx Pharmaceutical (RARE) United States $4.170B 0.00
Zai Lab (ZLAB) China $4.167B 0.00
Mirati Therapeutics (MRTX) United States $4.077B 0.00
Vir Biotechnology (VIR) United States $4.010B 0.00
Global Blood Therapeutics (GBT) United States $3.949B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.885B 84.89
Blueprint Medicines (BPMC) United States $3.767B 0.00
Bluebird Bio (BLUE) United States $3.723B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.539B 0.00
Amicus Therapeutics (FOLD) United States $3.301B 0.00
Arena Pharmaceuticals (ARNA) United States $3.290B 0.00
Halozyme Therapeutics (HALO) United States $3.159B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.999B 0.00
NeoGenomics (NEO) United States $2.899B 211.69
Denali Therapeutics (DNLI) United States $2.852B 0.00
UniQure (QURE) Netherlands $2.719B 0.00
Alkermes (ALKS) Ireland $2.672B 52.59
Viela Bio (VIE) United States $2.619B 0.00
Amarin (AMRN) Ireland $2.606B 0.00
Novavax (NVAX) United States $2.588B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.516B 0.00
Insmed (INSM) United States $2.479B 0.00
Alector (ALEC) United States $2.396B 0.00
Fate Therapeutics (FATE) United States $2.334B 0.00
Principia Biopharma (PRNB) United States $1.986B 0.00
Ligand Pharmaceuticals (LGND) United States $1.924B 74.94
Eidos Therapeutics (EIDX) United States $1.891B 0.00
Inovio Pharmaceuticals (INO) United States $1.878B 0.00
Epizyme (EPZM) United States $1.729B 0.00
Zymeworks (ZYME) Canada $1.648B 0.00
Adverum Biotechnologies (ADVM) United States $1.628B 0.00
Sangamo Therapeutics (SGMO) United States $1.582B 0.00
Twist Bioscience (TWST) United States $1.510B 0.00
Mesoblast (MESO) Australia $1.496B 0.00
Akcea Therapeutics (AKCA) United States $1.496B 0.00
PHARMA MAR SA (PHMMF) Spain $1.494B 0.00
Editas Medicine (EDIT) United States $1.487B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.482B 0.00
Zealand Pharma (ZEAL) Denmark $1.464B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.446B 0.00
Intra-Cellular Therapies (ITCI) United States $1.420B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Beam Therapeutics (BEAM) United States $1.405B 0.00
Arcus Biosciences (RCUS) United States $1.384B 0.00
REGENXBIO (RGNX) United States $1.375B 0.00
I-Mab (IMAB) China $1.361B 0.00
Mersana Therapeutics (MRSN) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.329B 9.28
NGM Biopharmaceuticals (NGM) United States $1.326B 0.00
Arvinas (ARVN) United States $1.287B 0.00
Revance Therapeutics (RVNC) United States $1.218B 0.00
Cytokineticsorporated (CYTK) United States $1.192B 0.00
Myriad Genetics (MYGN) United States $1.187B 61.23
Intellia Therapeutics (NTLA) United States $1.060B 0.00
Compugen (CGEN) Israel $1.007B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.979B 0.00
Athenex (ATNX) United States $0.971B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.882B 0.00
Heska (HSKA) United States $0.841B 0.00
Sorrento Therapeutics (SRNE) United States $0.809B 0.00
Cue Biopharma (CUE) United States $0.763B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.750B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.750B 0.00
Cara Therapeutics (CARA) United States $0.731B 0.00
Kala Pharmaceuticals (KALA) United States $0.729B 0.00
Codexis (CDXS) United States $0.726B 0.00
Cellectis S.A (CLLS) France $0.723B 0.00
NextCure (NXTC) United States $0.720B 0.00
Morphic Holding (MORF) United States $0.711B 0.00
Kadmon Holdings (KDMN) United States $0.699B 0.00
Retrophin (RTRX) United States $0.681B 0.00
Alcobra (ARCT) United States $0.668B 0.00
Vericel (VCEL) United States $0.657B 121.33
ZIOPHARM Oncology Inc (ZIOP) United States $0.654B 0.00
Castle Biosciences (CSTL) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Vanda Pharmaceuticals (VNDA) United States $0.626B 5.36
Stemline Therapeutics (STML) United States $0.625B 0.00
Agenus (AGEN) United States $0.625B 0.00
Bellus Health (BLU) Canada $0.625B 0.00
NantKwest (NK) United States $0.612B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.606B 0.00
Dynavax Technologies (DVAX) United States $0.597B 0.00
Frequency Therapeutics (FREQ) United States $0.584B 0.00
DBV Technologies S.A (DBVT) France $0.568B 0.00
Athersys (ATHX) United States $0.556B 0.00
UROGEN PHARMA (URGN) United States $0.555B 0.00
Intrexon (PGEN) United States $0.551B 0.00
MeiraGTx Holdings (MGTX) United States $0.538B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.524B 0.00
Cel-Sci (CVM) United States $0.515B 0.00
AnaptysBio (ANAB) United States $0.509B 0.00
Clovis Oncology (CLVS) United States $0.498B 0.00
Anika Therapeutics (ANIK) United States $0.493B 15.86
VBI Vaccines (VBIV) United States $0.484B 0.00
BioDelivery Sciences (BDSI) United States $0.474B 24.95
Scholar Rock Holding (SRRK) United States $0.472B 0.00
Merus (MRUS) Netherlands $0.469B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.468B 0.00
AC Immune SA (ACIU) Switzerland $0.448B 0.00
Protagonist Therapeutics (PTGX) United States $0.445B 0.00
Prothena (PRTA) Ireland $0.435B 0.00
Puma Biotechnology (PBYI) United States $0.415B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.409B 0.00
Syros Pharmaceuticals (SYRS) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.387B 332.00
Albireo Pharma (ALBO) United States $0.386B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
MiMedx (MDXG) United States $0.382B 0.00
ANI Pharmaceuticals (ANIP) United States $0.375B 7.44
CytomX Therapeutics (CTMX) United States $0.375B 0.00
Precision BioSciences (DTIL) United States $0.371B 0.00
Kamada (KMDA) Israel $0.348B 14.49
Seres Therapeutics (MCRB) United States $0.345B 0.00
OSMOTICA PHARM (OSMT) United States $0.344B 0.00
Selecta Biosciences (SELB) United States $0.332B 0.00
WAVE Life Sciences (WVE) Singapore $0.326B 0.00
Geron (GERN) United States $0.313B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.307B 0.00
MannKind (MNKD) United States $0.303B 0.00
Menlo Therapeutics (MNLO) United States $0.301B 0.00
Verastem (VSTM) United States $0.297B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.296B 0.00
ChromaDex (CDXC) United States $0.281B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.273B 0.00
Pfenex (PFNX) United States $0.269B 0.00
Liquidia Technologies (LQDA) United States $0.268B 0.00
ADMA Biologics Inc (ADMA) United States $0.268B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Cellular Biomedicine (CBMG) United States $0.256B 0.00
Affimed (AFMD) Germany $0.252B 0.00
Spero Therapeutics (SPRO) United States $0.250B 0.00
HOOKIPA Pharma (HOOK) United States $0.250B 0.00
Gritstone Oncology (GRTS) United States $0.243B 0.00
Exicure (XCUR) United States $0.243B 0.00
Abeona Therapeutics (ABEO) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
Northwest Biotherapeutics (NWBO) United States $0.240B 0.00
Fortress Biotech (FBIO) United States $0.238B 0.00
XOMA (XOMA) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
POXEL SA FRANCE (PXXLF) France $0.217B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 3.05
Paratek Pharmaceuticals (PRTK) United States $0.201B 0.00
IBio (IBIO) United States $0.200B 0.00
IVERIC Bio (ISEE) United States $0.200B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
Pluristem Therapeutics (PSTI) Israel $0.196B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
TELA Bio (TELA) United States $0.194B 0.00
Aduro Biotech (ADRO) United States $0.191B 0.00
Kindred Biosciences (KIN) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.182B 0.00
Aytu Bioscience (AYTU) United States $0.176B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Five Prime Therapeutics (FPRX) United States $0.172B 0.00
Celyad SA (CYAD) Belgium $0.171B 0.00
Orgenesis (ORGS) United States $0.169B 0.00
Aptinyx (APTX) United States $0.168B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Cyclerion Therapeutics (CYCN) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Cerecor (CERC) United States $0.158B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
PHASEBIO PHARMA (PHAS) United States $0.145B 0.00
Trevena (TRVN) United States $0.143B 0.00
Arbutus Biopharma (ABUS) Canada $0.141B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Palatin Technologies (PTN) United States $0.135B 3.45
CorMedix Inc (CRMD) United States $0.134B 0.00
VolitionRX (VNRX) United States $0.133B 0.00
Theratechnologies (THTX) Canada $0.132B 0.00
Applied Genetic Technologies (AGTC) United States $0.131B 0.00
Enzo Biochem (ENZ) United States $0.126B 0.00
Antibe Therapeutics (ATBPF) Canada $0.119B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.118B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
AIT Therapeutics (XAIR) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.111B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Eton Pharmaceuticals (ETON) United States $0.108B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.101B 0.00
Windtree Therapeutics (WINT) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.094B 0.00
AquaBounty Technologies (AQB) United States $0.089B 0.00
Organovo Holdings (ONVO) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.084B 0.00
SESEN BIO, INC (SESN) United States $0.084B 0.00
Celsion (CLSN) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Proteostasis Therapeutics (PTI) United States $0.075B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Stealth BioTherapeutics (MITO) United States $0.071B 0.00
DiaMedica Therapeutics (DMAC) United States $0.068B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Apricus Biosciences (SEEL) United States $0.051B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.050B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Advaxis (ADXS) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
TrovaGene (CRDF) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
OvaScience (MLND) United States $0.042B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Titan Pharmaceuticals (TTNP) United States $0.034B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Curis (CRIS) United States $0.031B 0.00
TOCAGEN INC (TOCA) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.022B 0.00
VIVUS (VVUS) United States $0.019B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Unum Therapeutics (UMRX) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00